qXR-CTR vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 68/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

qXR-CTR

by Qure.ai

iCAC Device

by Bunkerhill Health

AI Verdict

While both tools leverage AI for cardiovascular assessment, they target different aspects and imaging modalities. qXR-CTR analyzes chest X-rays to measure cardiothoracic ratio for heart size and potential heart failure risk. In contrast, the iCAC Device processes chest CT scans to detect and quantify coronary artery calcium, aiding in early cardiovascular disease detection.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is a rapid, automated assessment of heart size and potential heart failure risk using readily available chest X-ray images. This tool is ideal for initial screenings or situations where a quick, cost-effective evaluation of cardiac enlargement is required without the need for more advanced imaging.

View qXR-CTR →

Choose iCAC Device if…

Choose iCAC Device if you aim for early and opportunistic detection and quantification of coronary artery calcium from routine, non-contrast chest CT scans to assess cardiovascular disease risk. This tool is particularly valuable for leveraging existing CT data to provide a more detailed and quantitative measure of atherosclerotic burden, aiding in proactive cardiovascular risk stratification.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	qXR-CTR	iCAC Device
Pricing	Unknown	Contact for pricing
Deployment	Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app.	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

qXR-CTR

Tool A (qXR-CTR) offers explicit features enhancing usability, such as annotated X-rays, structured reports in DICOM and JSON formats, AI overlays/contour localization, and a dedicated Qure.ai App for mobile and desktop access. These features suggest a more comprehensive and direct user experience for radiologists within their existing workflows.

Clinical Value

iCAC Device

Tool B (iCAC Device) provides a more direct and quantitative measure of cardiovascular disease risk by detecting and quantifying coronary artery calcium (CAC) from routine CT scans. Opportunistic identification of CAC from existing, non-dedicated scans offers significant value for early disease detection and risk stratification, which is a stronger clinical indicator than CTR for heart failure risk.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing, and no public pricing details or specific value propositions (e.g., ROI studies) are disclosed for either. Without this information, it is impossible to conduct a head-to-head comparison on pricing or value.

Enterprise Readiness

qXR-CTR

Tool A (qXR-CTR) explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in place, along with offering flexible deployment options (cloud, on-premise, hybrid) and supporting multiple data standards (DICOM, HL7 v2, FHIR, SNOMED CT, ICD-10). Tool B requires contacting the vendor for BAA and HIPAA details, indicating less upfront transparency on these critical enterprise requirements.

Innovation

iCAC Device

While both utilize AI for automation, Tool B (iCAC Device) demonstrates greater innovation by enabling opportunistic detection and quantification of coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This approach leverages existing imaging data for proactive cardiovascular disease risk assessment without requiring additional dedicated scans, offering a novel pathway for population health.

Support & Docs

qXR-CTR

Tool A (qXR-CTR) explicitly offers a 'Qure.ai App User's Manual', 'Gateway User Manual', and 'Platform API' documentation, along with mentioning 'support on mobile & web'. This indicates a more transparent and readily accessible suite of support and documentation resources for users compared to what is publicly available for Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	qXR-CTR	iCAC Device
Name	qXR-CTR	iCAC Device
Company	Qure.ai Technologies	Bunkerhill Health
Primary Function	Automates measurement of cardiothoracic ratio (CTR) from chest X-ray images for heart size assessment and potential heart failure risk.	Detects and quantifies coronary artery calcium (CAC) from routine, non-contrast, non-gated chest CT scans for early cardiovascular disease detection.
Tagline	AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment.	Building healthcare's system of action with AI for clinical reasoning and action.
Analyzed Modality	Chest X-ray images	Routine, non-contrast, non-gated chest CT scans

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary differences in the imaging modalities these AI tools analyze?

qXR-CTR is designed to analyze chest X-ray images to automate the measurement of the cardiothoracic ratio (CTR). In contrast, the iCAC Device analyzes routine, non-contrast, non-gated chest CT scans to detect and quantify coronary artery calcium.

What specific cardiovascular assessments do qXR-CTR and iCAC Device provide?

qXR-CTR aids in the assessment of heart size and potential heart failure risk by automating cardiothoracic ratio measurement. The iCAC Device detects and quantifies coronary artery calcium, aiding in early cardiovascular disease detection and risk stratification for coronary artery disease.

What are the quantitative outputs provided by each AI tool?

qXR-CTR provides an automated measurement of the cardiothoracic ratio. The iCAC Device delivers exact and four-category quantitative estimates of coronary artery calcium burden in Agatston units, along with a visual representation of estimated CAC segmentation.

Does either tool offer capabilities for opportunistic screening from existing scans?

Yes, the iCAC Device supports the opportunistic identification and quantification of coronary artery calcium from existing routine, non-gated chest CT scans. qXR-CTR focuses on automated CTR measurement from chest X-rays.